LIDAK PHARMACEUTICALS has a total of 29 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, machines and measurement are OCHI SHIGEO, SECRET OF YOUTH LTD and PHARMACO BEHAVIORAL ASS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 3 | |
#5 | Hong Kong | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Organic fine chemistry | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Specific use of cosmetics | |
#7 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Katz David H | 19 |
#2 | Katz Lee R | 9 |
#3 | Pope Laura E | 9 |
#4 | Marcelletti John F | 9 |
#5 | Khalil Mohammed H | 7 |
#6 | Kleinfeld Alan M | 5 |
#7 | Wilson Darcy B | 2 |
#8 | Mosier Donald E | 2 |
#9 | Khalil Mohammed N | 2 |
#10 | Marcelletti J F | 1 |
Publication | Filing date | Title |
---|---|---|
WO9953912A1 | Topical immunostimulation to induce langerhans cell migration | |
AU7735298A | Use of C18 to C26 aliphatic alcohols for the manufacture of medicament in the t reatment of hyperproliferative skin disorders | |
US5948822A | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols | |
US5470714A | One-step free fatty acid determination method | |
US5476996A | Human immune system in non-human animal | |
US5166219A | Systemic anti-inflammatory treatment | |
EP0457901A1 | Free fatty acid determination | |
WO9013216A2 | Inflammatory disease treatment | |
US5070107A | Systemic antiviral treatment | |
US5071879A | Systemic antiviral treatment |